| Comprehensive and integrated genomic characterization of adult soft tissue sarcomas AJ Lazar, MD McLellan, MH Bailey, CA Miller, EL Appelbaum, MG Cordes, ... Cell 171 (4), 950-965, 2017 | 824 | 2017 |
| Comprehensive genomic analysis of rhabdomyosarcoma reveals a landscape of alterations affecting a common genetic axis in fusion-positive and fusion-negative tumors JF Shern, L Chen, J Chmielecki, JS Wei, R Patidar, M Rosenberg, ... Cancer discovery 4 (2), 216-231, 2014 | 702 | 2014 |
| The Genomic Landscape of the Ewing Sarcoma Family of Tumors Reveals Recurrent STAG2 Mutation AS Brohl, DA Solomon, W Chang, J Wang, Y Song, S Sindiri, R Patidar, ... PLoS genetics 10 (7), e1004475, 2014 | 428 | 2014 |
| Durable tumor regression and overall survival in patients with advanced Merkel cell carcinoma receiving pembrolizumab as first-line therapy P Nghiem, S Bhatia, EJ Lipson, WH Sharfman, RR Kudchadkar, AS Brohl, ... Journal of Clinical Oncology 37 (9), 693-702, 2019 | 362 | 2019 |
| Safety of resuming anti-PD-1 in patients with immune-related adverse events (irAEs) during combined anti-CTLA-4 and anti-PD1 in metastatic melanoma MH Pollack, A Betof, H Dearden, K Rapazzo, I Valentine, AS Brohl, ... Annals of Oncology 29 (1), 250-255, 2018 | 340 | 2018 |
| Monogenic and polygenic determinants of sarcoma risk: an international genetic study ML Ballinger, DL Goode, I Ray-Coquard, PA James, G Mitchell, ... The Lancet Oncology 17 (9), 1261-1271, 2016 | 224 | 2016 |
| Avelumab in patients with previously treated metastatic Merkel cell carcinoma: long-term data and biomarker analyses from the single-arm phase 2 JAVELIN Merkel 200 trial SP D'Angelo, S Bhatia, AS Brohl, O Hamid, JM Mehnert, P Terheyden, ... Journal for Immunotherapy of Cancer 8 (1), 2020 | 176 | 2020 |
| Treatment pathway of bone sarcoma in children, adolescents, and young adults DR Reed, M Hayashi, L Wagner, O Binitie, DA Steppan, AS Brohl, ... Cancer 123 (12), 2206-2218, 2017 | 163 | 2017 |
| The Genomic Landscape of Merkel Cell Carcinoma and Clinicogenomic Biomarkers of Response to Immune Checkpoint Inhibitor Therapy TC Knepper, M Montesion, JS Russell, ES Sokol, GM Frampton, VA Miller, ... Clinical Cancer Research 25 (19), 5961-5971, 2019 | 145 | 2019 |
| The genomic landscape of malignant peripheral nerve sheath tumors: diverse drivers of Ras pathway activation AS Brohl, E Kahen, SJ Yoder, JK Teer, DR Reed Scientific reports 7 (1), 1-5, 2017 | 134 | 2017 |
| MultiDimensional ClinOmics for precision therapy of children and adolescent young adults with relapsed and refractory cancer: a report from the center for cancer research W Chang, AS Brohl, R Patidar, S Sindiri, JF Shern, JS Wei, YK Song, ... Clinical cancer research 22 (15), 3810-3820, 2016 | 109 | 2016 |
| Development and clinical application of an integrative genomic approach to personalized cancer therapy AV Uzilov, W Ding, MY Fink, Y Antipin, AS Brohl, C Davis, CY Lau, ... Genome medicine 8, 1-20, 2016 | 99 | 2016 |
| Germline CARD11 Mutation in a Patient with Severe Congenital B Cell Lymphocytosis AS Brohl, JR Stinson, HC Su, T Badgett, CD Jennings, G Sukumar, ... Journal of clinical immunology 35, 32-46, 2015 | 95 | 2015 |
| First-line avelumab in a cohort of 116 patients with metastatic Merkel cell carcinoma (JAVELIN Merkel 200): primary and biomarker analyses of a phase II study SP D'Angelo, C Lebbé, L Mortier, AS Brohl, N Fazio, JJ Grob, N Prinzi, ... Journal for immunotherapy of cancer 9 (7), 2021 | 91 | 2021 |
| Combination of Ipilimumab and Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes for Patients with Metastatic Melanoma JE Mullinax, ML Hall, S Prabhakaran, J Weber, N Khushalani, Z Eroglu, ... Frontiers in Oncology 8, 44, 2018 | 87 | 2018 |
| Clinical, pathological, and genomic features of EWSR1-PATZ1 fusion sarcoma JA Bridge, J Sumegi, M Druta, MM Bui, E Henderson-Jackson, K Linos, ... Modern Pathology 32 (11), 1593-1604, 2019 | 85 | 2019 |
| Three-year survival, correlates and salvage therapies in patients receiving first-line pembrolizumab for advanced Merkel cell carcinoma P Nghiem, S Bhatia, EJ Lipson, WH Sharfman, RR Kudchadkar, AS Brohl, ... Journal for immunotherapy of cancer 9 (4), 2021 | 84 | 2021 |
| Age‐stratified risk of unexpected uterine sarcoma following surgery for presumed benign leiomyoma AS Brohl, L Li, V Andikyan, SG Običan, A Cioffi, K Hao, JT Dudley, ... The oncologist 20 (4), 433-439, 2015 | 84 | 2015 |
| Consensus and controversies regarding the treatment of rhabdomyosarcoma SC Borinstein, D Steppan, M Hayashi, DM Loeb, MS Isakoff, O Binitie, ... Pediatric blood & cancer 65 (2), e26809, 2018 | 83 | 2018 |
| Frequent inactivating germline mutations in DNA repair genes in patients with Ewing sarcoma AS Brohl, R Patidar, CE Turner, X Wen, YK Song, JS Wei, KA Calzone, ... Genetics in Medicine 19 (8), 955-958, 2017 | 76 | 2017 |
